To determine vaccination impact on anti-tumor immunity, B6/129J mice were subcutaneously injected with (M23 + R848) PLGA and (D23 + R848)PLGA nanoparticles 13 days prior to subcutaneous challenge with KRAS pancreatic cancer cells (KPC). The gene discussed is KRAS; the disease is neoplasm.